Viewing Study NCT05156905


Ignite Creation Date: 2025-12-25 @ 3:22 AM
Ignite Modification Date: 2026-03-05 @ 1:04 AM
Study NCT ID: NCT05156905
Status: TERMINATED
Last Update Posted: 2024-10-09
First Post: 2021-12-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer
Sponsor: University of California, San Diego
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration-resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate cancer View
None Docetaxel View
None Wnt pathway View
None Cirmtuzumab View
None ROR1 View